loadpatents
name:-0.017796039581299
name:-0.0049641132354736
name:-0.0077450275421143
TAMRAZ; Wilma Patent Filings

TAMRAZ; Wilma

Patent Applications and Registrations

Patent applications and USPTO patent grants for TAMRAZ; Wilma.The latest application filed is for "compositions and methods involving polymer, solvent and high viscosity liquid carrier material".

Company Profile
10.6.23
  • TAMRAZ; Wilma - San Jose CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Compositions And Methods Involving Polymer, Solvent And High Viscosity Liquid Carrier Material
App 20220280646 - WRIGHT; Jeremy C. ;   et al.
2022-09-08
Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
Grant 11,285,217 - Wright , et al. March 29, 2
2022-03-29
Compositions Comprising 5-cholesten-3, 25-diol, 3-sulfate (25hc3s) Or Pharmaceutically Acceptable Salt Thereof And At Least One Cyclic Oligosaccharide
App 20210169898 - Ren; Shunlin ;   et al.
2021-06-10
Use Of Oxygenated Cholesterol Sulfates (ocs) To Treat Inflammatory Skin Disease And Skin Lesions
App 20210169902 - Ren; Shunlin ;   et al.
2021-06-10
Compositions And Methods Involving Polymer, Solvent, And High Viscosity Liquid Carrier Material
App 20210015924 - WRIGHT; Jeremy C. ;   et al.
2021-01-21
Depot Formulations
App 20200383957 - TAMRAZ; Wilma ;   et al.
2020-12-10
Depot Formulations
App 20200352852 - TAMRAZ; Wilma ;   et al.
2020-11-12
Depot formulations
Grant 10,682,340 - Tamraz , et al.
2020-06-16
Depot formulations
Grant 10,668,011 - Tamraz , et al.
2020-06-02
Compositions And Methods Involving Polymer, Solvent, And High Viscosity Liquid Carrier Material
App 20200085829 - WRIGHT; Jeremy C. ;   et al.
2020-03-19
Use Of Oxygenated Cholesterol Sulfates (ocs) To Treat Inflammatory Skin Disease And Skin Lesions
App 20190374554 - Ren; Shunlin ;   et al.
2019-12-12
Compositions Comprising 5-cholesten-3, 25-diol, 3-sulfate (25hc3s) Or Pharmaceutically Acceptable Salt Thereof And At Least One
App 20190269695 - Ren; Shunlin ;   et al.
2019-09-05
Compositions And Methods Involving Polymer, Solvent, And High Viscosity Liquid Carrier Material
App 20190255179 - WRIGHT; Jeremy C. ;   et al.
2019-08-22
Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
Grant 10,226,532 - Wright , et al.
2019-03-12
Compositions And Methods Involving Polymer, Solvent, And High Viscosity Liquid Carrier Material
App 20180140605 - WRIGHT; Jeremy C. ;   et al.
2018-05-24
Depot Formulations
App 20180117016 - TAMRAZ; Wilma ;   et al.
2018-05-03
Compositions and Methods Involving Polymer, Solvent, and High Viscosity Liquid Carrier Material
App 20180036412 - WRIGHT; Jeremy C. ;   et al.
2018-02-08
Depot Formulations
App 20180000729 - TAMRAZ; Wilma ;   et al.
2018-01-04
Injectable controlled release composition comprising high viscosity liquid carrier
Grant 9,737,605 - Wright , et al. August 22, 2
2017-08-22
Compositions And Methods Involving Polymer, Solvent, And High Viscosity Liquid Carrier Material
App 20170143721 - WRIGHT; Jeremy C. ;   et al.
2017-05-25
Compositions and methods involving polymer, solvent, and high viscosity liquid carrier material
Grant 9,572,812 - Wright , et al. February 21, 2
2017-02-21
Crystalline And Amorphous Forms Of Palonosetron Hydrochloride
App 20160214976 - Mossi; Waldo ;   et al.
2016-07-28
Compositions And Methods Involving Polymer, Solvent, And High Viscosity Liquid Carrier Material
App 20160206618 - WRIGHT; Jeremy C. ;   et al.
2016-07-21
Injectable Controlled Release Composition Comprising High Viscosity Liquid Carrier
App 20160038596 - WRIGHT; Jeremy C. ;   et al.
2016-02-11
Amorphous Forms Of Palonosetron Hydrochloride
App 20150291581 - MOSSI; Waldo ;   et al.
2015-10-15
Compositions And Methods Involving Polymer, Solvent, And High Viscosity Liquid Carrier Material
App 20140308352 - WRIGHT; Jeremy C. ;   et al.
2014-10-16
Amorphous Forms Of Palonosetron Hydrochloride
App 20140171646 - MOSSI; Waldo ;   et al.
2014-06-19
High Concentration Formulations of Opioids and Opioid Derivatives
App 20110136847 - Chan; Tai Wah ;   et al.
2011-06-09
High concentration formulations of opioids and opioid derivatives
App 20040102476 - Chan, Tai Wah ;   et al.
2004-05-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed